Impact of Induction Chemotherapy and Preoperative Chemoradiotherapy on Operative Morbidity and Mortality in Patients with Locoregional Adenocarcinoma of the Stomach or Gastroesophageal Junction
β Scribed by Kazumasa Fujitani; Jaffer A. Ajani; Christopher H. Crane; Barry W. Feig; Peter W. Pisters; Nora Janjan; Garrett L. Walsh; Stephen G. Swisher; Ara A. Vaporciyan; David Rice; Angela Welch; Jackie Baker; Josephine Faust; Paul F. Mansfield
- Book ID
- 111771837
- Publisher
- Springer
- Year
- 2007
- Tongue
- English
- Weight
- 201 KB
- Volume
- 14
- Category
- Article
- ISSN
- 1068-9265
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND Patients with localized esophageal carcinoma often develop locoregional and distant disease recurrence. The current study investigated the outcome of a new chemotherapy combination as induction therapy before chemoradiotherapy. ## METHODS Fortyβthree patients with resec
## Abstract ## BACKGROUND. Tumor viability assessed by pathologic analysis of resected specimens in patients with preoperatively treated esophageal adenocarcinoma (EAC) is a prognostic indicator. The feasibility of induction chemotherapy followed by concurrent chemoradiotherapy (CCRT) and surgery
## Abstract ## BACKGROUND. Thromboembolic events (TEEs) are considered common in patients with gastroesophageal carcinoma, but their frequency at baseline and during chemotherapy is not known. Because prophylactic anticoagulation results in improved overall survival (OS) of solid tumor patients, t